Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Vital Signs as Predictor Factors of Intravenous Immunoglobulin Resistance in Patients With Kawasaki Disease.

Gámez-González LB, Hamada H, Cisneros Castolo M, Honda T, Yasukawa K, Takanashi JI.

Clin Pediatr (Phila). 2018 Sep;57(10):1148-1153. doi: 10.1177/0009922818759320. Epub 2018 Feb 27.

PMID:
29486579
2.

Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.

Sato S, Kawashima H, Kashiwagi Y, Hoshika A.

Int J Rheum Dis. 2013 Apr;16(2):168-72. doi: 10.1111/1756-185X.12082.

PMID:
23773640
3.

Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.

Chantasiriwan N, Silvilairat S, Makonkawkeyoon K, Pongprot Y, Sittiwangkul R.

Paediatr Int Child Health. 2018 Aug;38(3):209-212. doi: 10.1080/20469047.2018.1471381. Epub 2018 May 17.

PMID:
29768976
4.

Verification of Current Risk Scores for Kawasaki Disease in Korean Children.

Shin J, Lee H, Eun L.

J Korean Med Sci. 2017 Dec;32(12):1991-1996. doi: 10.3346/jkms.2017.32.12.1991.

5.

Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.

Kuo HC, Liang CD, Wang CL, Yu HR, Hwang KP, Yang KD.

Acta Paediatr. 2010 Oct;99(10):1578-83. doi: 10.1111/j.1651-2227.2010.01875.x. Epub 2010 Jun 7.

PMID:
20491705
6.

Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease.

Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, Kobayashi T, Morikawa A.

Circulation. 2006 Jun 6;113(22):2606-12. Epub 2006 May 30.

PMID:
16735679
8.

Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.

Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.

Pediatr Rheumatol Online J. 2017 Mar 21;15(1):17. doi: 10.1186/s12969-017-0149-1.

9.

Prediction of intravenous immunoglobulin resistance in Kawasaki disease in an East China population.

Tang Y, Yan W, Sun L, Huang J, Qian W, Ding Y, Lv H.

Clin Rheumatol. 2016 Nov;35(11):2771-2776. Epub 2016 Aug 5.

PMID:
27491972
10.

Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort.

Fabi M, Andreozzi L, Corinaldesi E, Bodnar T, Lami F, Cicero C, Tchana B, Landini C, Sprocati M, Bigucci B, Balsamo C, Sogno Valin P, Di Fazzio G, Iughetti L, Valletta E, Marchetti F, Donti A, Lanari M.

Eur J Pediatr. 2019 Mar;178(3):315-322. doi: 10.1007/s00431-018-3297-5. Epub 2018 Nov 29.

PMID:
30499051
11.

The Combined Usefulness of the Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Predicting Intravenous Immunoglobulin Resistance with Kawasaki Disease.

Kawamura Y, Takeshita S, Kanai T, Yoshida Y, Nonoyama S.

J Pediatr. 2016 Nov;178:281-284.e1. doi: 10.1016/j.jpeds.2016.07.035. Epub 2016 Aug 12.

PMID:
27526622
12.

Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.

Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.

Arthritis Rheum. 2013 Mar;65(3):805-14. doi: 10.1002/art.37815.

13.
14.

Utility of ferritin as a predictor of the patients with Kawasaki disease refractory to intravenous immunoglobulin therapy.

Yamamoto N, Sato K, Hoshina T, Kojiro M, Kusuhara K.

Mod Rheumatol. 2015;25(6):898-902. doi: 10.3109/14397595.2015.1038430. Epub 2015 May 27.

PMID:
25849851
15.

N-terminal pro-brain natriuretic peptide (NT proBNP) as a predictive indicator of initial intravenous immunoglobulin treatment failure in children with Kawasaki disease: a retrospective study.

Kim SY, Han MY, Cha SH, Jeon YB.

Pediatr Cardiol. 2013;34(8):1837-43. doi: 10.1007/s00246-013-0724-2. Epub 2013 Jun 7. Erratum in: Pediatr Cardiol. 2014 Jan;35(1):189.

PMID:
23744100
16.

Immunoglobulin G values before treatment are correlated with the responsiveness to initial intravenous immunoglobulin therapy for Kawasaki disease.

Yanagimoto K, Nomura Y, Masuda K, Hirabayashi M, Morita Y, Yoshishige M, Ueno K, Eguchi T, Kawano Y.

Int Arch Allergy Immunol. 2014;164(2):83-8. doi: 10.1159/000363383. Epub 2014 Jun 4.

PMID:
24903098
17.

Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease.

Berdej-Szczot E, Małecka-Tendera E, Gawlik T, Firek-Pędras M, Szydłowski L, Gawlik A.

Kardiol Pol. 2017;75(3):261-266. doi: 10.5603/KP.a2016.0179. Epub 2016 Dec 20.

18.

Role of the Egami Score in Predicting Intravenous Immunoglobulin Resistance in Kawasaki Disease Among Different Ethnicities.

Loomba RS, Raskin A, Gudausky TM, Kirkpatrick E.

Am J Ther. 2016 Nov/Dec;23(6):e1293-e1299.

PMID:
25611359
19.

Risk factors and derived formosa score for intravenous immunoglobulin unresponsiveness in Taiwanese children with Kawasaki disease.

Lin MT, Chang CH, Sun LC, Liu HM, Chang HW, Chen CA, Chiu SN, Lu CW, Chang LY, Wang JK, Wu MH.

J Formos Med Assoc. 2016 May;115(5):350-5. doi: 10.1016/j.jfma.2015.03.012. Epub 2015 Apr 21.

20.

Variability in Response to Intravenous Immunoglobulin in the Treatment of Kawasaki Disease.

Downie ML, Manlhiot C, Latino GA, Collins TH, Chahal N, Yeung RS, McCrindle BW.

J Pediatr. 2016 Dec;179:124-130.e1. doi: 10.1016/j.jpeds.2016.08.060. Epub 2016 Sep 19.

PMID:
27659027

Supplemental Content

Support Center